Abstract
The 2024 Brain Tumor Segmentation Meningioma Radiotherapy (BraTS-MEN-RT)challenge aims to advance automated segmentation algorithms using the largestknown multi-institutional dataset of radiotherapy planning brain MRIs withexpert-annotated target labels for patients with intact or post-operativemeningioma that underwent either conventional external beam radiotherapy orstereotactic radiosurgery. Each case includes a defaced 3D post-contrastT1-weighted radiotherapy planning MRI in its native acquisition space,accompanied by a single-label "target volume" representing the gross tumorvolume (GTV) and any at-risk post-operative site. Target volume annotationsadhere to established radiotherapy planning protocols, ensuring consistencyacross cases and institutions. For pre-operative meningiomas, the target volumeencompasses the entire GTV and associated nodular dural tail, while forpost-operative cases, it includes at-risk resection cavity margins asdetermined by the treating institution. Case annotations were reviewed andapproved by expert neuroradiologists and radiation oncologists. Participatingteams will develop, containerize, and evaluate automated segmentation modelsusing this comprehensive dataset. Model performance will be assessed using thelesion-wise Dice Similarity Coefficient and the 95% Hausdorff distance. Thetop-performing teams will be recognized at the Medical Image Computing andComputer Assisted Intervention Conference in October 2024. BraTS-MEN-RT isexpected to significantly advance automated radiotherapy planning by enablingprecise tumor segmentation and facilitating tailored treatment, ultimatelyimproving patient outcomes.